Recent publications WCN studies

• A comprehensive analysis of female participation in cardiovascular trials involving the WCN investigator networkNetherlands Heart Journal - Abstract - Westendorp, dr. I.C.D.; Schut, drs. A. November 2025
• Evolocumab in patients without a previous myocardial infarction or strokeThe New England Journal of Medicine - Abstract - Cornel, prof. dr. J.H. - VESALIUS-CV - ASCVD November 2025
• Antibody-mediated LOX-1 inhibition in patients with residual inflammation after myocardial infarction: a randomized phase 2 trialNature Medicine - Abstract - GOLDILOX - ASCVD September 2025
• Design and Rationale of Lp(a)HORIZON Trial: Assessing the Effect of Lipoprotein(a) Lowering With Pelacarsen on Major Cardiovascular Events in Patients With CVD and Elevated Lp(a)Am Heart J - HORIZON - ASCVD September 2025
• ESSENCE trial: Targeting APOC3 with Olezarsen in Moderate HypertriglyceridemiaNew England Journal of Medicine - Abstract - ESSENCE - ASCVD August 2025
• Finerenone According to Frailty in Heart Failure: A Prespecified Analysis of the FINEARTS-HF Randomized Clinical TrialJAMA Cardiol. - Abstract - Linssen, dr. G.C.M. - FINEARTS-HF - Heart failure August 2025